Los Angeles Capital Management LLC bought a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 161,912 shares of the company's stock, valued at approximately $10,749,000. Los Angeles Capital Management LLC owned 0.06% of Ryan Specialty at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in RYAN. Champlain Investment Partners LLC raised its stake in shares of Ryan Specialty by 28.0% during the 1st quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company's stock worth $274,022,000 after purchasing an additional 1,079,505 shares during the period. Principal Financial Group Inc. lifted its position in Ryan Specialty by 148.9% during the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company's stock valued at $56,545,000 after purchasing an additional 509,548 shares during the last quarter. Bessemer Group Inc. increased its holdings in shares of Ryan Specialty by 33.9% in the 1st quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company's stock worth $106,886,000 after buying an additional 488,067 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Ryan Specialty by 132.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company's stock valued at $48,425,000 after buying an additional 476,126 shares in the last quarter. Finally, 2Xideas AG purchased a new stake in shares of Ryan Specialty during the 1st quarter valued at $19,765,000. 84.82% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, Director Nicholas Dominic Cortezi sold 1,500 shares of the firm's stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $65.02, for a total transaction of $97,530.00. Following the sale, the director now owns 25,123 shares of the company's stock, valued at $1,633,497.46. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, Director Nicholas Dominic Cortezi sold 1,500 shares of the firm's stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $65.02, for a total transaction of $97,530.00. Following the completion of the transaction, the director now directly owns 25,123 shares in the company, valued at $1,633,497.46. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the stock in a transaction that occurred on Wednesday, August 14th. The shares were sold at an average price of $65.18, for a total transaction of $1,709,866.94. Following the completion of the transaction, the executive vice president now owns 24,845 shares in the company, valued at $1,619,397.10. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 107,136 shares of company stock valued at $6,960,032 over the last ninety days. 11.10% of the stock is owned by insiders.
Ryan Specialty Price Performance
Shares of Ryan Specialty stock traded up $0.07 on Tuesday, hitting $71.87. 226,882 shares of the company traded hands, compared to its average volume of 877,196. The company has a market cap of $18.82 billion, a P/E ratio of 93.21, a P/E/G ratio of 1.62 and a beta of 0.62. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 12-month low of $41.49 and a 12-month high of $73.10. The firm's 50-day simple moving average is $67.71 and its 200 day simple moving average is $61.37.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting analysts' consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. During the same period in the prior year, the firm earned $0.32 EPS. The company's revenue was up 20.5% compared to the same quarter last year. Analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current fiscal year.
Ryan Specialty Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th will be paid a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.61%. Ryan Specialty's payout ratio is currently 57.14%.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the company. Bank of America increased their price objective on Ryan Specialty from $75.00 to $84.00 and gave the stock a "buy" rating in a report on Thursday, October 10th. Wells Fargo & Company raised their price objective on shares of Ryan Specialty from $63.00 to $70.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 10th. The Goldman Sachs Group increased their target price on Ryan Specialty from $64.00 to $72.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 9th. JPMorgan Chase & Co. upped their price target on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an "underweight" rating in a research note on Friday, August 2nd. Finally, Citigroup boosted their target price on shares of Ryan Specialty from $56.00 to $62.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, Ryan Specialty currently has a consensus rating of "Hold" and an average target price of $70.33.
Read Our Latest Report on RYAN
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report